Neuroprotectin D1 Attenuates Laser-induced Choroidal Neovascularization in Mouse

被引:1
|
作者
Sheets, Kristopher G. [1 ,2 ]
Zhou, Yongdong [1 ,2 ]
Ertel, Monica K. [1 ,2 ]
Knott, Eric J. [1 ,2 ]
Regan, Cornelius E., Jr. [1 ,2 ]
Elison, Jasmine R. [1 ,2 ]
Gordon, William C. [1 ,2 ]
Gjorstrup, Per [3 ]
Bazan, Nicolas G. [1 ,2 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA USA
[2] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA
[3] Resolvyx Pharmaceut Inc, Bedford, MA USA
来源
MOLECULAR VISION | 2010年 / 16卷 / 38期
基金
美国国家卫生研究院;
关键词
POLYUNSATURATED FATTY-ACIDS; ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; DOCOSAHEXAENOIC ACID; MACULAR DEGENERATION; OXIDATIVE STRESS; CELL-SURVIVAL; AGE; ANGIOGENESIS; PERMEABILITY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: To examine the effects of neuroprotectin D1 (NPD1), a stereospecific derivative of docosahexaenoic acid, on choroidal neovascularization (CNV) in a laser-induced mouse model. Specifically, this was assessed by clinically grading laser-induced lesions, measuring leakage area, and volumetrically quantifying vascular endothelial cell proliferation. Methods: C57Bl/6 mice were treated with vehicle control or NPD1, and choroidal neovascularization was induced by laser rupture of Bruch's membrane; treatment was administered throughout the first week of recovery. One and two weeks after CNV induction, fundus fluorescein angiography was performed. Angiograms were clinically graded to assess leakage severity, while leakage area was measured by image analysis of angiograms. Proliferation of vascular endothelial cells was evaluated volumetrically by three-dimensional laser confocal immunofluorescent microscopy of cytoskeletal, nuclear, and endothelial cell markers. Results: At seven days after CNV induction, NPD1-treated mice had 60% fewer clinically relevant lesions than controls, dropping to 80% fewer by 14 days. NPD1 mice exhibited 25% smaller leakage area than controls at 7 days and 44% smaller area at 14 days. Volumetric immunofluorescence revealed 46% less vascular endothelial cell volume in 7-day NPD1-treated mice than in 7-day controls, and by 14 days NPD1 treatment was 68% lower than controls. Furthermore, comparison of 7-and 14-day volumes of NPD1-treated mice revealed a 50% reduction at 14 days. Conclusions: NPD1 significantly inhibits choroidal neovascularization. There are at least two possible mechanisms that could explain the neuroprotective action of NPD1. Ultimately, nuclear factor-kappa B could be inhibited with a reduction in cyclooxygenase-2 (COX-2) to reduce vascular endothelial growth factor (VEGF) expression, and/or activation of the resolution phase of the inflammatory response/survival pathways could be upregulated. Moreover, NPD1 continues to be effective after treatment is concluded, suggesting sustained protection and highlighting the potential applicability of this lipid mediator in preventing or ameliorating endothelial cell growth in pathoangiogenesis.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [41] Enhancing Reliability of the Laser-Induced Choroidal Neovascularization Mouse Model: Insights From a New Study
    Chen, Jing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (10) : 6535 - 6535
  • [42] A Two-Stage Laser-Induced Mouse Model of Subretinal Fibrosis Secondary to Choroidal Neovascularization
    Little, Karis
    Llorian-Salvador, Maria
    Tang, Miao
    Du, Xuan
    O'Shaughnessy, Orlaith
    McIlwaine, Gemma
    Chen, Mei
    Xu, Heping
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (04):
  • [43] Alexandrite Laser-Induced Choroidal Neovascularization Successfully Treated With Aflibercept
    Diafas, Asterios
    Stampouli, Despoina
    Dastiridou, Anna
    Androudi, Sofia
    Brazitikos, Periklis
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [44] Antiangiogenic Effects of Intraconazole on Laser-Induced Choroidal Neovascularization in Mice
    Won, Jae Yon
    Park, Young-Hoon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [45] Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration
    Bora, PS
    Hu, ZW
    Tezel, TH
    Sohn, JH
    Kang, SG
    Cruz, JMC
    Bora, NS
    Garen, A
    Kaplan, HJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) : 2679 - 2684
  • [46] Evaluation of Aflibercept in a Laser-Induced Model of Choroidal Neovascularization in Pigs
    Culp, David
    Patel, Samirkumar Rajnikant
    Gilger, Brian C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [47] Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat
    Takehana, Y
    Kurokawa, T
    Kitamura, T
    Tsukahara, Y
    Akahane, S
    Kitazawa, M
    Yoshimura, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (02) : 459 - 466
  • [48] Endogenous Osteopontin Involvement in Laser-Induced Choroidal Neovascularization in Mice
    Fujita, Norihito
    Fujita, Shuko
    Ogata, Nahoko
    Matsuoka, Masato
    Okada, Yuka
    Kon, Shigeyuki
    Uede, Toshimitsu
    Saika, Shizuya
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (13) : 9310 - 9315
  • [49] A simplified method for the quantitation of laser-induced choroidal neovascularization in the rat
    Spee, CK
    Barron, E
    Hinton, DR
    Ryan, SJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U288 - U288
  • [50] Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin
    Yong Wun Cho
    Yong Seop Han
    In Young Chung
    Seong Jae Kim
    Seong Wook Seo
    Ji Myong Yoo
    Jong Moon Park
    International Journal of Ophthalmology, 2014, 7 (06) : 952 - 958